Back

Coronary artery disease in TAVI, if and when to treat?

29 August 2017 (12:12 - 12:30)
Organised by:
Congress Presentation Part of: Tough decisions around TAVI Aortic valve surgery ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Kentaro Hayashida

Kansai Medical University, Osaka (Japan)

4 More presentations in this session

Presentation thumbnail
When is TAVI futile?
Professor C. Otto (Seattle, US)
Slides Video
Presentation thumbnail
Increased gradient post TAVI: what to accept during follow-up
Professor N. Ajmone Marsan (Leiden, NL)
Slides Video
Presentation thumbnail
TAVI with atrial fibrillation: which antithrombotic regimen?
Professor G. Montalescot (Paris, FR)
Slides Video
Presentation thumbnail
Asymptomatic leaflet thrombosis after TAVI: what to do?
Professor F. Neumann (Bad Krozingen, DE)
Slides Video

Access the full session

Session thumbnail
Tough decisions around TAVI

The Event

Event poster

ESC Congress 2017

29 August 2017 12:12 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular risk and coronary artery disease burden in TAVI patients
29 June 2021
thumbnail
Webinar
Percutaneous interventions in patients with coronary artery disease and specific clinical conditions - IC Core Curriculum 6
9 November 2022
thumbnail
Congress Session
20 years of TAVI: the remaining unmet needs
23 June 2023
thumbnail
Congress Presentation
Impact of TAVR on GDMT in patients with severe aortic stenosis and HFrEF
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources